| Literature DB >> 35003021 |
Jingjing Luo1, Lidong Wang1, Lei Song1, Zhao-Qing Luo2.
Abstract
Ubiquitination is a commonly used post-translational modification (PTM) in eukaryotic cells, which regulates a wide variety of cellular processes, such as differentiation, apoptosis, cell cycle, and immunity. Because of its essential role in immunity, the ubiquitin network is a common target of infectious agents, which have evolved various effective strategies to hijack and co-opt ubiquitin signaling for their benefit. The intracellular pathogen Legionella pneumophila represents one such example; it utilizes a large cohort of virulence factors called effectors to modulate diverse cellular processes, resulting in the formation a compartment called the Legionella-containing vacuole (LCV) that supports its replication. Many of these effectors function to re-orchestrate ubiquitin signaling with distinct biochemical activities. In this review, we highlight recent progress in the mechanism of action of L. pneumophila effectors involved in ubiquitination and discuss their roles in bacterial virulence and host cell biology.Entities:
Keywords: effector; immunity; intracellular pathogen; ubiquitin; virulence
Year: 2021 PMID: 35003021 PMCID: PMC8727461 DOI: 10.3389/fmicb.2021.790442
Source DB: PubMed Journal: Front Microbiol ISSN: 1664-302X Impact factor: 5.640
FIGURE 1Canonical eukaryotic ubiquitination by the three-enzyme cascade. Canonical ubiquitination is initiated by E1-mediated acyl adenylation on the carboxyl terminus of Ub by hydrolyzing an ATP molecule, followed by a linkage of Ub to the active cysteine residue of E1 and the release of AMP. The Ub on E1 is then delivered to the active cysteine residue of E2, which works together with E3 to transfer Ub to lysine residue of substrates. E3 ligases are categorized into three different classes: RING (Really Interesting New Gene) type, HECT (Homologous to the E6-AP Carboxyl Terminus) type, and the RBR (RING-between-RING) type. While the RING domain-containing E3 ligases transfer ubiquitin from the thioester-conjugated E2 directly to the isopeptide bond of lysine residues in the substrates, HECT- or RBR-containing E3 enzymes receives ubiquitin on a cysteine residue from E2, which is then delivered to substrate proteins.
L. pneumophila Dot/Icm effectors involved in ubiquitination pathway.
| Effectors (Gene ID) | Aliases | Interactor/substrate | Enzymatic activity | Function | References |
|
| |||||
| lpg0171 | legU1 | SKP1, Cullin 1, BAT3 | F-Box protein, E3 ligase | Unknown | |
| lpg1111 | RavN | Unknown | U-box-like protein, E3 ligase | Unknown |
|
| lpg1408 | licA | SKP1 | F-Box protein | Unknown |
|
| lpg2144/lpp2082 | legAU13/ankB | SKP1, Cullin 1, Parvin B | F-Box protein, E3 ligase | Intracellular replication; Recruitment of ubiquitinated proteins to the LCV | |
| lpg2224 | PpgA | Unknown | F-Box protein | Unknown |
|
| lpg2370 | HipA | Unknown | E3 ligase | Unknown |
|
| lpg2455 | GobX | Unknown | U-Box protein, E3 ligase | Unknown |
|
| lpg2498 | MavJ | Unknown | E3 ligase | Unknown |
|
| lpg2525 | Unknown | F-Box protein | Unknown | ||
| lpg2577 | MavM | Unknown | E3 ligase | Unknown |
|
| lpg2830 | LegU2/LubX | Clk1, SidH | U-Box protein, E3 ligase | SidH degradation | |
|
| |||||
| lpg2452 | LegA14/SdcB | Unknown | Cys-His-Asp domain protein, E3 ligase | Unknown |
|
| lpg2510 lpg2511 | SidC SdcA | Rab10 | Cys-His-Asp domain protein, E3 ligase | Recruitment of ER vesicles and ubiquitinated proteins including Rab10 to LCV | |
|
| |||||
| lpg0234 lpg2153 lpg2156 lpg2157 | SidE SdeC SdeB SdeA | Rab1, Rab6a, Rab30, Rab33b, Rtn4, FAM134C | All-in-one ubiquitin conjugation enzyme; Deubiquitinase | Intracellular replication; regulation of ubiquitin dynamics on the LCV; Recruitment of ER markers to the LCV; ER tubule Rearrangement. | |
| lpg2147 | MavC | UBE2N | Transglutaminase activity | inhibits NFκB activation | |
|
| |||||
| lpg0160 | RavD | Unknown | Cleaves linear Ub chains | Benefits L. pneumophila by suppressing host immune responses |
|
| lpg0227 | Ceg7 | Unknown | Targets K6-, K11-, K48-, and K63- Ub chains | Unknown | |
| lpg1148 | LupA | LegC3 | Typical bacterial CE clan Dubs | Removes Ub modification of LegC3 |
|
| lpg1621 | LotB | Sec22b | Targets K63- Ub chains | Abolishes the interaction between Sec22b on the LCV and the syntaxin 3 | |
| lpg2248 | LotA | Unknown | Targets K13-, K48-, and K63- Ub chains | Removes ubiquitinated proteins from the surface of LCV |
|
| lpg2529 | LotC/Lem27 | Rab10 | Targets K6-, K11-, K48-, and K63- Ub chains | Removes ubiquitinated Rab10 from the surface of LCV | |
FIGURE 2Ubiquitination by the SidE family and its regulation. (A) Phosphoribosyl ubiquitination and de-ubiquitination. Phosphoribosyl ubiquitination induced by SidEs is initiated by ADP-ribosylation of Ub at Arg42 by its mART activity, leading to the release of nicotinamide and the production of ADPR-Ub. The phosphodiester bond in ADPR-Ub is subsequently the cleaved by the phosphodiesterase (PDE) domain of SidEs, which is accompanied by the transfer of phosphoribosyl Ub to serine residues of substrate proteins and the release of AMP. (B) Glutamylation and de-glutamylation of members of the SidE family. In host cells, SidJ binds to CaM via an IQ motif in its carboxyl end. The complex functions as a glutamylase to attack the first glutamate residue of the ExE motif in the mART domain of SidEs by polyglutamylation, leading to abolishment of the activity of the mART, and thus the inactivation of Ub ligase activity of the SidEs. Despite its high-level similarity to SidJ, SdjA selectively inhibits SdeB and SdeC by glutamylation. In addition to the glutamylase activity, SdjA also exhibits a deglutamylase activity toward glutamylated SdeA.
FIGURE 3Reversible atypical ubiquitination by MavC and MvcA. Ubiquitination catalyzed by MavC is initiated by the formation of a thioester linkage between the active residue Cys74 and Gln40 of Ub, concomitant with the release of ammonium. The acylated MavC then reacts with the amine donor from a lysine (Lys92) in UBE2N to form an intermolecular isopeptide bond, resulting in ubiquitination of UBE2N. MvcA, a structural ortholog of MavC, functions as a deubiquitinase to cleave the isopeptide bond between Ub and UBE2N catalyzed by MavC, leading to the release of UBE2N and deamidated Ub.